| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 15/05/2024 | 15:00 | Business Wire | Taro to Release Full Year Results on May 20, 2024 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 14/05/2024 | 14:20 | Edgar (US Regulatory) | Form SC 13E3/A - Going private transaction by certain issuers: [Amend] | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 08/05/2024 | 15:07 | Business Wire | Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 15/04/2024 | 14:00 | Business Wire | Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd. | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 15/02/2024 | 14:36 | Edgar (US Regulatory) | Form SC 13E3 - Going private transaction by certain issuers | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 30/01/2024 | 19:18 | PR Newswire (US) | Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 30/01/2024 | 13:00 | PR Newswire (US) | Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 26/01/2024 | 15:00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 25/01/2024 | 23:06 | Business Wire | Taro Provides Results for December 31, 2023 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 19/01/2024 | 22:15 | Business Wire | Taro to Release Third Quarter Results on January 25, 2024 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 17/01/2024 | 22:35 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 17/01/2024 | 22:30 | PR Newswire (Canada) | Taro Announces Merger Agreement with Sun Pharma | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 26/10/2023 | 23:00 | Business Wire | Taro Provides Results for September 30, 2023 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 19/10/2023 | 22:30 | Business Wire | Taro to Release Second Quarter Results on October 26, 2023 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 27/07/2023 | 02:36 | Business Wire | Taro Provides Results for the Quarter Ended June 30, 2023 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 19/07/2023 | 22:00 | Business Wire | Taro to Release First Quarter Results on July 26, 2023 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 19/07/2023 | 13:00 | PR Newswire (US) | Krensavage Asset Management Opposes Sun's Lowball Bid for Taro | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 30/06/2023 | 15:00 | Business Wire | Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 29/06/2023 | 22:32 | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 28/06/2023 | 23:01 | Edgar (US Regulatory) | Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 26/05/2023 | 23:03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 24/05/2023 | 01:00 | Business Wire | Taro Provides Results for Year Ended March 31, 2023 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 18/05/2023 | 22:46 | Business Wire | Taro to Release Full Year Results on May 23, 2023 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 24/01/2023 | 23:43 | Business Wire | Taro Provides Results for December 31, 2022 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 19/01/2023 | 23:02 | Business Wire | Taro to Release Third Quarter Results on January 24, 2023 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 28/10/2022 | 00:39 | Business Wire | Taro Provides Results for September 30, 2022 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 24/10/2022 | 18:37 | Business Wire | Taro to Release Second Quarter Results on October 27, 2022 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 15/08/2022 | 12:35 | TipRanks | H.C. Wainwright Keeps Their Buy Rating on Taro Pharmaceutical (TARO) | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 27/07/2022 | 23:28 | Business Wire | Taro Provides Results for the Quarter Ended June 30, 2022 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |
| 26/07/2022 | 22:10 | Business Wire | Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022 | NYSE:TARO | Taro Pharmaceutical Industries Ltd |